AU2010274293B9 - Skin external-preparation composition - Google Patents

Skin external-preparation composition Download PDF

Info

Publication number
AU2010274293B9
AU2010274293B9 AU2010274293A AU2010274293A AU2010274293B9 AU 2010274293 B9 AU2010274293 B9 AU 2010274293B9 AU 2010274293 A AU2010274293 A AU 2010274293A AU 2010274293 A AU2010274293 A AU 2010274293A AU 2010274293 B9 AU2010274293 B9 AU 2010274293B9
Authority
AU
Australia
Prior art keywords
cnp
bnp
preparation
dermatitis
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010274293A
Other languages
English (en)
Other versions
AU2010274293B2 (en
AU2010274293B8 (en
AU2010274293A1 (en
Inventor
Kyoko Endo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Igisu Co Ltd
Original Assignee
Igisu Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igisu Co Ltd filed Critical Igisu Co Ltd
Publication of AU2010274293A1 publication Critical patent/AU2010274293A1/en
Publication of AU2010274293B2 publication Critical patent/AU2010274293B2/en
Application granted granted Critical
Publication of AU2010274293B8 publication Critical patent/AU2010274293B8/en
Publication of AU2010274293B9 publication Critical patent/AU2010274293B9/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AU2010274293A 2009-07-23 2010-07-23 Skin external-preparation composition Ceased AU2010274293B9 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2009172589 2009-07-23
JP2009-172589 2009-07-23
JP2010-134600 2010-06-11
JP2010134600 2010-06-11
PCT/JP2010/062459 WO2011010732A1 (ja) 2009-07-23 2010-07-23 皮膚外用剤組成物

Publications (4)

Publication Number Publication Date
AU2010274293A1 AU2010274293A1 (en) 2012-02-23
AU2010274293B2 AU2010274293B2 (en) 2013-06-06
AU2010274293B8 AU2010274293B8 (en) 2013-07-04
AU2010274293B9 true AU2010274293B9 (en) 2013-08-29

Family

ID=43499204

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010274293A Ceased AU2010274293B9 (en) 2009-07-23 2010-07-23 Skin external-preparation composition

Country Status (14)

Country Link
US (4) US20120208756A1 (https=)
EP (1) EP2457581B1 (https=)
JP (5) JP4834190B2 (https=)
KR (2) KR101533695B1 (https=)
CN (4) CN102470163B (https=)
AU (1) AU2010274293B9 (https=)
BR (1) BR112012001491B1 (https=)
CA (1) CA2768810C (https=)
DK (1) DK2457581T3 (https=)
ES (1) ES2456502T3 (https=)
MX (1) MX2012001024A (https=)
NZ (1) NZ597797A (https=)
RU (2) RU2572694C2 (https=)
WO (1) WO2011010732A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120208756A1 (en) * 2009-07-23 2012-08-16 Igisu Co., Ltd Composition for external preparation for skin
MX353295B (es) 2011-01-21 2018-01-08 Endo Kyoko Agente para el tratamiento de la alopecia.
ES2488740B1 (es) * 2012-10-10 2015-06-11 J. Álvaro GALIANO RAMOS Formulación cosmética y dermatologica para el alivio del prurito
CN104367925A (zh) * 2014-11-07 2015-02-25 济南高达信息技术有限公司 一种治疗红皮病的中药洗剂及其制备方法
CA2986086A1 (en) * 2015-05-29 2016-12-08 Igisu Co., Ltd. Cyclyc peptide, and medicine, external preparation and cosmetic each containing said cyclic peptide
EP3310392A4 (en) 2015-06-19 2019-03-27 Global Health Solutions, LLC PETROLATUM-BASED DISTRIBUTION SYSTEMS AND FOR ACTIVE SUBSTANCES
JP7253220B2 (ja) * 2015-07-31 2023-04-06 株式会社 イギス Ｃｎｐ環状ペプチド並びに該環状ペプチドを含む医薬品、外用剤および化粧料
CN105617360B (zh) * 2015-12-04 2018-12-21 中国农业大学 C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用
BR112018072467A2 (pt) * 2016-05-05 2019-02-19 Aquestive Therapeutics, Inc. composições farmacêuticas com permeação aumentada
WO2017192921A1 (en) 2016-05-05 2017-11-09 Monosol Rx, Llc Enhanced delivery epinephrine compositions
WO2018056907A1 (en) * 2016-09-21 2018-03-29 Agency For Science, Technology And Research Methods and compositions for inhibiting skin inflammation and determining cancer susceptibility
JP7125862B2 (ja) * 2018-05-29 2022-08-25 小林製薬株式会社 外用組成物
JP2019214520A (ja) * 2018-06-12 2019-12-19 花王株式会社 角層剥離改善剤
CN110302194B (zh) * 2019-07-23 2023-01-31 广州市皮肤病防治所(广州市性病防治监测中心) 一种具有抗炎和皮肤屏障保护作用的桉叶素联合糖皮质激素的复方制剂
US11419917B2 (en) 2020-04-07 2022-08-23 Drora Shevy Treatment for SARS-CoV-2 and other coronaviruses
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment
JP7466939B2 (ja) * 2022-08-31 2024-04-15 東洋ビューティ株式会社 Ｏ／ｄ相組成物及び水中油型乳化組成物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110489A1 (ja) * 2003-06-13 2004-12-23 Daiichi Asubio Pharma Co., Ltd. Ｔｈ１型免疫疾患予防又は治療用医薬組成物
EP1810716A1 (de) * 2005-12-23 2007-07-25 Deutsches Zentrum für Luft- und Raumfahrt e.V. Verfahren zur Bräunung der Haut
JP2008509746A (ja) * 2004-08-11 2008-04-03 アルザ・コーポレーシヨン ナトリウム利尿ペプチドを経皮送達する器具および方法
JP2008162987A (ja) * 2006-12-31 2008-07-17 Toshiko Koide 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法
WO2009046861A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
JP2809533B2 (ja) 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
JPH05207891A (ja) 1991-03-08 1993-08-20 Shionogi & Co Ltd 脳性ナトリウム利尿ペプチドの製造方法
WO1994020534A1 (en) 1993-03-03 1994-09-15 Mayo Foundation For Medical Education And Research Vasonatrin peptide and analogs thereof
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
US5965533A (en) 1997-05-23 1999-10-12 Baxter International Inc. Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
WO2000018422A1 (fr) 1998-09-28 2000-04-06 Santen Pharmaceutical Co., Ltd. Promoteurs de secretion lacrymale ou gouttes ophtalmologiques contenant des peptides natriuretiques comme principes actifs pour traiter la keratoconjonctivite
JP3799465B2 (ja) 1998-09-28 2006-07-19 参天製薬株式会社 ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤
US6407211B1 (en) * 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
IL142118A0 (en) 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
JP3676707B2 (ja) * 2001-07-18 2005-07-27 三菱電機株式会社 車両用交流発電機の固定子およびその製造方法
WO2004022003A2 (en) 2002-09-06 2004-03-18 University Of South Florida Materials and methods for treatment of allergic diseases
US20050271596A1 (en) 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US7648962B2 (en) * 2002-11-26 2010-01-19 Biocon Limited Natriuretic compounds, conjugates, and uses thereof
WO2004047871A2 (en) 2002-11-26 2004-06-10 Nobex Corporation Modified naturetic compounds, conjugates, and uses thereof
US20040161435A1 (en) * 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions
WO2005000095A2 (en) 2003-06-20 2005-01-06 Mayo Foundation For Medical Education And Research Isoforms of brain natriuretic peptide
JP2007525213A (ja) 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
CA2554599A1 (en) 2004-01-27 2005-08-11 Compugen Usa, Inc. Novel brain natriuretic peptide variants and methods of use thereof
ES2465141T3 (es) * 2004-03-31 2014-06-05 Kazuwa Nakao Remedio o medicamento preventivo para la artritis
WO2005094890A1 (ja) 2004-03-31 2005-10-13 Kazuwa Nakao 身長増加用組成物
DE102004048576A1 (de) * 2004-10-04 2006-04-13 Deutsches Zentrum für Luft- und Raumfahrt e.V. Methode zur Bräunung der Haut
CN101501067B (zh) 2006-08-08 2013-01-16 梅约医学教育与研究基金会 利尿和利尿钠的多肽
JPWO2008032450A1 (ja) 2006-09-15 2010-01-21 国立大学法人京都大学 脂肪肝の予防剤および／または治療剤
WO2008082524A1 (en) 2006-12-19 2008-07-10 National Stem Cell Inc. Embryonic germ cell secreted product derived topical compositions and methods of use thereof
JP2010168283A (ja) 2007-04-24 2010-08-05 Yamaguchi Univ ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤
JP5207316B2 (ja) 2007-05-10 2013-06-12 国立大学法人名古屋大学 腹膜線維化抑制用医薬組成物
US20100204145A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of a peptide as a therapeutic agent
EP2217620A2 (en) * 2007-11-21 2010-08-18 BioMarin Pharmaceutical Inc. Variants of c-type natriuretic peptide
US8741842B2 (en) 2008-07-02 2014-06-03 Mayo Foundation For Medical Education And Research Chimeric natriuretic polypeptides with unique pharmacologic profiles
US8642550B2 (en) * 2008-10-24 2014-02-04 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides without hypotensive inducing capability
US8150603B2 (en) 2008-11-26 2012-04-03 Caterpillar Inc. Engine control system having fuel-based timing
US8455438B2 (en) 2008-12-29 2013-06-04 Mayo Foundation For Medical Education And Research Natriuretic polypeptides for reducing or preventing restenosis
PT2432489T (pt) 2009-05-20 2016-12-07 Biomarin Pharm Inc Variantes do péptido natriurético de tipo c
US20120208756A1 (en) * 2009-07-23 2012-08-16 Igisu Co., Ltd Composition for external preparation for skin
JP2011024973A (ja) * 2009-07-24 2011-02-10 Mitsumasa Maeda 電子ペーパー付き便蓋
WO2011024973A1 (ja) 2009-08-27 2011-03-03 株式会社 イギス 鼻炎治療剤
ITPG20090061A1 (it) 2009-11-27 2011-05-28 Andrea Marcantonini Impianto mobile per la produzione di calcestruzzo
MX353295B (es) 2011-01-21 2018-01-08 Endo Kyoko Agente para el tratamiento de la alopecia.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110489A1 (ja) * 2003-06-13 2004-12-23 Daiichi Asubio Pharma Co., Ltd. Ｔｈ１型免疫疾患予防又は治療用医薬組成物
US20070270337A1 (en) * 2003-06-13 2007-11-22 Daiichi Asubio Pharma Co., Ltd. Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
JP2008509746A (ja) * 2004-08-11 2008-04-03 アルザ・コーポレーシヨン ナトリウム利尿ペプチドを経皮送達する器具および方法
EP1810716A1 (de) * 2005-12-23 2007-07-25 Deutsches Zentrum für Luft- und Raumfahrt e.V. Verfahren zur Bräunung der Haut
JP2008162987A (ja) * 2006-12-31 2008-07-17 Toshiko Koide 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法
WO2009046861A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent

Also Published As

Publication number Publication date
CN105999230A (zh) 2016-10-12
US20180099028A1 (en) 2018-04-12
RU2012103653A (ru) 2013-08-27
AU2010274293B2 (en) 2013-06-06
CN110339346A (zh) 2019-10-18
KR20120049169A (ko) 2012-05-16
JP2016006058A (ja) 2016-01-14
CN102470163A (zh) 2012-05-23
CN110339346B (zh) 2023-06-27
NZ597797A (en) 2013-11-29
JP4834190B2 (ja) 2011-12-14
BR112012001491B1 (pt) 2022-03-15
US20120208756A1 (en) 2012-08-16
JP2018135381A (ja) 2018-08-30
JP6055518B2 (ja) 2016-12-27
ES2456502T3 (es) 2014-04-22
EP2457581A1 (en) 2012-05-30
US9358269B2 (en) 2016-06-07
JP2012017316A (ja) 2012-01-26
CN104189893B (zh) 2018-10-23
CA2768810A1 (en) 2011-01-27
HK1171193A1 (en) 2013-03-22
DK2457581T3 (da) 2014-03-31
JP5778440B2 (ja) 2015-09-16
AU2010274293B8 (en) 2013-07-04
MX2012001024A (es) 2012-04-11
CA2768810C (en) 2014-05-20
EP2457581B1 (en) 2014-01-08
RU2015150099A3 (https=) 2019-07-17
AU2010274293A1 (en) 2012-02-23
US9968654B2 (en) 2018-05-15
KR101533695B1 (ko) 2015-07-06
WO2011010732A1 (ja) 2011-01-27
JP6337071B2 (ja) 2018-06-06
KR101226165B1 (ko) 2013-01-24
JP2017061556A (ja) 2017-03-30
JPWO2011010732A1 (ja) 2013-01-07
CN104189893A (zh) 2014-12-10
US20140072520A1 (en) 2014-03-13
US20160250293A1 (en) 2016-09-01
KR20120130273A (ko) 2012-11-29
EP2457581A4 (en) 2012-12-12
CN102470163B (zh) 2016-06-15
CN105999230B (zh) 2022-06-24
BR112012001491A2 (pt) 2020-01-28
RU2015150099A (ru) 2017-07-27
RU2572694C2 (ru) 2016-01-20
US10946072B2 (en) 2021-03-16

Similar Documents

Publication Publication Date Title
AU2010274293B9 (en) Skin external-preparation composition
KR20070089907A (ko) 피부 병태, 질환 또는 질병의 치료를 위한 태아 피부 세포단백질 조성물 및 이의 제조 방법 및 이의 사용 방법
KR20130018739A (ko) 항균 펩티드 격리 화합물을 사용한 피부 질환 및 장애의 치료를 위한 조성물 및 방법
JP5144690B2 (ja) Ｐｌｇｆ−１を含む医薬品及び化粧品組成物
JP2010116405A6 (ja) Ｐｌｇｆ−１を含む医薬品及び化粧品組成物
HK1171193B (en) Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ SKIN EXTERNAL-PREPARATION COMPOSITION

TH Corrigenda

Free format text: IN VOL 27 , NO 21 , PAGE(S) 3359 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME IGISU CO., LTD., APPLICATION NO. 2010274293, UNDER INID (54) CORRECT THE TITLE TO READ SKIN EXTERNAL-PREPARATION COMPOSITION

SREP Specification republished
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired